Cathay Biotech (688065.SH) disclosed its report for the first quarter of 2024. The company achieved operating revenue during the reporting period...
According to Zhitong Finance App News, Cathay Biotech (688065.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 685 million yuan during the reporting period, an increase of 35.43% over the previous year. Net profit attributable to shareholders of listed companies was 105 million yuan, an increase of 83.25% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 103 million yuan, an increase of 100.99% over the previous year. Basic earnings per share were 0.18 yuan/share.